2Demandante CG, Troyer DA, Miles TP. Multiple primary malignant neoplasms:ease report and a comprehensive review of the literature [ J ]. Am J Clin Oncol, 2003,26( 1 ) :79-83.
6Demandante CG,Troyer DA,Miles TP.Multiple primary malignant neoplasms:case report and a comprehensive review of the literature.Am J Clin Oncol 2003;26:79-83.
7Hayat MI,Howlader N,Reichman ME,Edwards BK.Cancer statistics,trends,and multiple primary cancer analyses from the Surveillance,Epidemiology,and End Results(SEER)Program.Oncologist 2007;12:20-37.
8Fernandez-Ruiz M,Guerra-Vales JM,Castelbon-Fernandez FJ,Llenas-Garcia J,Caurcel-Diaz L,Colina-Ruizdelgado F.Multiple primary malignancies in Spanish patients with hepatocellular carcinoma:analysis of a hospital-based tumor registry.J Gastroenterol Hepatol 2009;24:1424-1430.
9Cramer D W, Finn 0 1. Epidemiologic perspective on immune-surveillance in cancer [J]. Curr Opin Immunol, 2011 ,23 ( 2) : 265 - 71.
10Ferreri A J, Abrey L E, Blay J Y, et al. Summary statement on primary central nervous system lymphomas from the eighth international conference on malignant lymphoma] JJ. J Clin Oncol , 2003, 21 (12) :2407 -14.
